Recent Strategies for Delivery of Plant-Based Active Ingredients
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".
Deadline for manuscript submissions: 25 May 2025 | Viewed by 788
Special Issue Editors
Interests: drug delivery; cyclodextrin; drug/cyclodextrin inclusion complexes; nanoparticles; nanostructures; supramolecular chemistry; anticancer therapy; antibacterial therapy; neurodegenerative disease; autoimmune pathologies
Special Issues, Collections and Topics in MDPI journals
Interests: drug delivery; cyclodextrin; drug/cyclodextrin inclusion complexes; nanoparticles; nanostructures; supramolecular chemistry; anticancer therapy; antibacterial therapy; neurodegenerative disease; autoimmune pathologies
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Plants are a rich source of several classes of valuable phytochemical compounds with proven biological activity. In recent years, great attention has been paid to natural molecules because they are safe, have extraordinary properties and very little side effects. Therefore, their combination with synthetic chemotherapeutics and antibacterials can be an effective strategy that can inhibit tumour and bacterial growth and multidrug resistance, and achieve synergistic drug action, reducing adverse effects.
However, factors such as their low stability, poor solubility, and bioavailability limit their food, cosmetic, and pharmaceutical applications.
In this regard, innovative strategies are needed to improve the solubility of plant-derived bioactive compounds, mask unwanted flavours, increase their stability during processing, storage, or gastrointestinal digestion, and effectively transport them to target tissues where they can exert their biological activity and support human health.
The above drawbacks can often be overcome by encapsulating bioactive ingredients in suitable delivery systems, including lipid-based nanosystems, polymer-based nanoparticles, protein-based carriers, inorganic-based delivery systems, or drug–cyclodextrin inclusion complexes.
Carriers enhance the chemical and physical properties of natural molecules and allow for controlled release at the target site without altering their characteristics.
Dr. Federica De Gaetano
Prof. Dr. Cinzia Anna Ventura
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery
- polymeric nanoparticles
- lipid nanosystems
- inclusion complexes
- polymeric cyclodextrins
- protein carriers
- inorganic delivery systems
- nanostructured carriers
- chemical–physical characterization
- in vitro/ex vivo/in vivo evaluation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
